Aliases & Classifications for Pyoderma

About this section

Summaries for Pyoderma

About this section
Wikipedia:71 Pyoderma means any skin disease that is pyogenic (has pus). These include superficial bacterial... more...

MalaCards based summary: Pyoderma is related to pyoderma gangrenosum and collagenous colitis, and has symptoms including exanthema, pruritus and pustular rash. An important gene associated with Pyoderma is PSTPIP1 (Proline-Serine-Threonine Phosphatase Interacting Protein 1), and among its related pathways are Overview of nanoparticle effects and EBV LMP1 signaling. Affiliated tissues include skin, breast and neutrophil, and related mouse phenotypes are hematopoietic system and integument.

Disease Ontology:11 Pyoderma is a skin infectious disease where the infection is pyogenic causing the formation of pus.

Related Diseases for Pyoderma

About this section

Diseases related to Pyoderma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 255)
idRelated DiseaseScoreTop Affiliating Genes
1pyoderma gangrenosum33.8CXCL8, F3, TNF
2collagenous colitis29.5CXCL8, NOD2, TNF
3burns29.4CXCL8, MMP9, TNF
4myiasis29.3CXCL8, MEFV, TNF
5pyogenic sterile arthritis, pyoderma gangrenosum, and acne12.0
6pyogenic arthritis, pyoderma gangrenosum and acne12.0
7pyoderma gangrenosum-acne-suppurative hidradenitis syndrome11.7
8crohn's disease11.1
9impetigo11.1
10actinic prurigo polymorphic light eruption, hereditary10.9
11polydactyly, postaxial, types a1 and b10.8
12ileocolitis10.8
13cutaneous diphtheria10.8
14radial ray agenesis10.3IL1R1, PSTPIP1
15nemaline myopathy 1, autosomal dominant or recessive10.3PSTPIP1, TNF
16dermatosis papulosa nigra10.2NOD2, TNF
17conidiobolomycosis10.2CXCL8, TNF
18myeloid neoplasms associated with pdgfrb rearrangement10.2MEFV, TNF
19tau syndrome10.2MEFV, TNF
20thymic neuroendocrine carcinoma10.2CXCL8, TNF
21candidiasis, familial, 4, autosomal recessive10.2MEFV, TNF
22colitis10.2
23coronary arterial fistulas10.2CXCL8, NOD2
24amyotrophic lateral sclerosis type 510.2NOD2, TNF
25senile reticular retinal degeneration10.2CXCL8, IL1R1, TNF
26muckle-wells syndrome10.2IL1R1, MEFV
27ulcerative colitis10.2
28functional gastric disease10.2IL1R1, NOD2, TNF
29amyotrophic lateral sclerosis type 1410.2CXCL8, NOD2, TNF
30bare lymphocyte syndrome, type i10.2CXCL8, IL1R1, TNF
31parkinson disease 1110.2CXCL8, NOD2, TNF
32warthin tumor10.2IL1R1, TNF
33pyloric stenosis, infantile hypertrophic, 210.2MEFV, PSTPIP1, TNF
34benign neonatal seizures10.2IL1R1, MEFV, TNF
35patellar tendinitis10.2CXCL8, IFNA2, IL1R1
36pulmonary artery coming from the aorta10.2MEFV, NOD2, PSTPIP1
37benign eccrine breast spiradenoma10.2CXCL8, NOD2, TNF
38wilkes stevenson syndrome10.1CXCL8, IL1R1, MEFV
39uterine ligament clear cell adenocarcinoma10.1CXCL8, NOD2, TNF
40strawberry gallbladder10.1CXCL8, MEFV, TNF
41meier-gorlin syndrome 310.1MEFV, NOD2, TNF
42major depressive disorder and accelerated response to antidepressant drug treatment10.1CXCL8, ITGB2, TNF
43esotropia10.1IFNA2, ITGB2, MEFV
44childhood malignant hemangiopericytoma10.1CXCL8, NOD2, TNF
45acute gonococcal cystitis10.1CXCL8, NOD2
46senile cataract10.1IFNA2, MEFV, TNF
47acne10.1
48acute kidney failure10.1CXCL8, ITGB2, PSTPIP1, TNF
49tetanus10.1MEFV, TNF
50inflammatory bowel disease10.1

Comorbidity relations with Pyoderma via Phenotypic Disease Network (PDN):


Peripheral Vascular DiseaseDeficiency Anemia
Heart DiseaseAcute Cystitis
Decubitus Ulcer

Graphical network of the top 20 diseases related to Pyoderma:



Diseases related to pyoderma

Symptoms & Phenotypes for Pyoderma

About this section

UMLS symptoms related to Pyoderma:


exanthema, pruritus, pustular rash

MGI Mouse Phenotypes related to Pyoderma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.7BTK, F3, IL1R1, ITGB2, MEFV, MMP9
2MP:00107717.5BTK, F3, IL1R1, ITGB2, MEFV, MMP9
3MP:00053877.0BTK, F3, IL1R1, ITGB2, MEFV, MMP10

Drugs & Therapeutics for Pyoderma

About this section

Drugs for Pyoderma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Anti-Bacterial AgentsPhase 4, Phase 311226
2Anti-Infective AgentsPhase 4, Phase 322062
3
Minocyclineapproved, investigationalPhase 323110118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline HCl
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
NCGC00178854-01
NSC 141993
NSC141993
Novo-Minocycline
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
4Pharmaceutical SolutionsPhase 3, Phase 28192
5
Tacrolimusapproved, investigationalPhase 21102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
6Dermatologic AgentsPhase 25806
7Antibodies, MonoclonalPhase 2, Phase 14039
8AntibodiesPhase 2, Phase 16394
9Antirheumatic AgentsPhase 210956
10ImmunoglobulinsPhase 2, Phase 16394
11Calcineurin InhibitorsPhase 21622
12Immunosuppressive AgentsPhase 213086
13
Amoxicillinapproved, vet_approved46526787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
14
Infliximabapproved392170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
15Clavulanic Acid170
16beta-Lactamase Inhibitors294
17Amoxicillin-Potassium Clavulanate Combination137
18Gastrointestinal Agents8402
19Vaccines6611

Interventional clinical trials:

(show all 24)
idNameStatusNCT IDPhase
1Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)WithdrawnNCT00202891Phase 4
2Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyUnknown statusNCT00203697Phase 3
3An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02326740Phase 3
4An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02315417Phase 3
5A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma GangrenosumTerminatedNCT02318914Phase 3
6Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma GangrenosumCompletedNCT01882504Phase 2
7A Phase II Open Label Study of Xilonix in Subjects With Pyoderma GangrenosumCompletedNCT01965613Phase 2
8Canakinumab for Pyoderma GangrenosumCompletedNCT01302795Phase 2
9Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
10An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma GangrenosumRecruitingNCT03137160Phase 2
11Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma GangrenosumRecruitingNCT02733094Phase 1, Phase 2
12Efficacy and Safety of APD334 in Patients With Pyoderma GangrenosumRecruitingNCT03072953Phase 2
13Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoRecruitingNCT02902822Phase 2
14Safety and Efficacy Study of Humira in Treatment of Pyoderma GangrenosumWithdrawnNCT00730717Phase 2
15Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma GangrenosumWithdrawnNCT00690846Phase 2
16Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic FactorsUnknown statusNCT00933296
17Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseCompletedNCT00791557
18Prevalence of RHD, Pyoderma and Scabies in Children in FijiCompletedNCT00284843
19Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in FijiCompletedNCT00436891
20Incidence of Group A Strep Pharyngitis in School Children in FijiCompletedNCT00284882
21Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern TerritoryCompletedNCT00884728
22Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)CompletedNCT01406275
23Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesRecruitingNCT01952275
24A Real World, Observational Registry of Chronic Wounds and UlcersRecruitingNCT02280733

Search NIH Clinical Center for Pyoderma


Cochrane evidence based reviews: pyoderma

Genetic Tests for Pyoderma

About this section

Anatomical Context for Pyoderma

About this section

MalaCards organs/tissues related to Pyoderma:

36
Skin, Breast, Neutrophil, T cells, Myeloid, Lung, Bone

Publications for Pyoderma

About this section

Articles related to Pyoderma:

(show top 50)    (show all 835)
idTitleAuthorsYear
1
Establishing a canine superficial pyoderma model. (27891724)
2017
2
An Unusual Association of Chronic Recurrent Multifocal Osteomyelitis, Pyoderma Gangrenosum, and Takayasu Arteritis. (28042129)
2017
3
Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis. (27384061)
2016
4
Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy. (27617462)
2016
5
Pyoderma gangrenosum and necrotizing fasciitis-like opportunistic invasive cutaneous fungal infection. (27126743)
2016
6
Pyoderma Vegetans Misdiagnosed as Verrucous Carcinoma. (26825160)
2016
7
Malignant Pyoderma Associated with Granulomatosis with Polyangiitis (Wegener Granulomatosis) as a Unique Indication for Facial Vascularized Composite Allotransplantation: Part I. (27219252)
2016
8
Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. (27473454)
2016
9
Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis. (27799888)
2016
10
Rifampicin treatment of canine pyoderma due to multidrug-resistant meticillin-resistant staphylococci: a retrospective study of 32 cases. (28025853)
2016
11
Facial Pyoderma Gangrenosum Presenting With Cranial Nerve VII Palsy and Cicatricial Ectropion. (27893584)
2016
12
Pediatric pyoderma gangrenosum: is it just big wounds on little adults? (27916349)
2016
13
High level of serum human interleukin-18 in a patient with pyogenic arthritis, pyoderma gangrenosum and acne syndrome. (27505688)
2016
14
Pyoderma gangrenosum of the eyelid. (27085278)
2016
15
Postoperative Pyoderma Gangrenosum: AA Clinical Review of Published Cases. (27489052)
2016
16
Gene Therapy for Pyoderma Gangrenosum: Optimal Transfection Conditions and Effect of Drugs on Gene Delivery in the HaCaT Cell Line Using Cationic Liposomes. (27159975)
2016
17
Post Surgical Pyoderma Gangrenosum in flap surgery: diagnostic clues and treatment recommendations. (27938245)
2016
18
Pyoderma gangrenosum with extensive pulmonary involvement. (27658239)
2016
19
Pyoderma gangrenosum and its syndromic forms: Evidence for a link with autoinflammation. (27106250)
2016
20
Successful Treatment of Pyoderma Gangrenosum after Augmentation Mastopexy Using Vacuum Therapy. (27975008)
2016
21
Severe pyoderma gangrenosum in association with a flame burn. (27583260)
2016
22
Intralesional methotrexate as an adjuvant treatment for pyoderma gangrenosum: A case report. (27451930)
2016
23
Cutaneous Angiosarcoma Simulating as Pyoderma in a Middle-aged Indian female: A Rare Case Report. (27904196)
2016
24
Severe Bilateral Lower Extremity Pyoderma Gangrenosum. (27980702)
2016
25
Superficial granulomatous pyoderma: A great mimicker. (28004648)
2016
26
Pyoderma gangrenosum after trauma in a dog. (27108868)
2016
27
Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C. (27345376)
2016
28
Delayed diagnosis of bullous pyoderma gangrenosum with acute myelogenous leukemia. (27811462)
2016
29
Autoinflammation in pyoderma gangrenosum and its syndromic form PASH. (27943240)
2016
30
Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma. (28027314)
2016
31
Pyoderma gangrenosum associated with mantle cell lymphoma. (27559522)
2016
32
Pyoderma gangrenosum mimicking mediastinitis after cardiac surgery: a case study. (27286670)
2016
33
Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case. (27051318)
2016
34
Bullous Pyoderma Gangrenosum With Subungual Involvement Associated With Ulcerative Colitis. (27893467)
2016
35
Unusual cause of breast wound: postoperative pyoderma gangrenosum. (27444684)
2016
36
High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum. (27502191)
2016
37
Pyoderma gangrenosum: A clinico-epidemiological study. (27549869)
2016
38
Antimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in Brazil. (26833540)
2016
39
Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. (27864925)
2016
40
Hyperbaric Oxygen Therapy for the Adjunctive Treatment of Pyoderma Gangrenosum: A Case Report. (27192719)
2016
41
Heterogeneity of blastomycosis-like pyoderma: A selection of cases from the last 35 years. (26776602)
2016
42
Successful treatment of large refractory pyoderma gangrenosum-like presentation of granulomatosis with polyangiitis with rituximab. (27126548)
2016
43
Concomitant Pyoderma Gangrenosum and Erythema Nodosum in a Patient With Ulcerative Colitis. (27474109)
2016
44
Ocular pyoderma gangrenosum: A systematic review. (27836332)
2016
45
Pyoderma Gangrenosum-A New Manifestation of Wilson Disease? (27194899)
2016
46
Pyoderma Gangrenosum in the Urologist Clinic. (27867335)
2016
47
The diagnosis you wish you had never operated on: Pyoderma gangrenosum misdiagnosed as necrotizing fasciitis-a case report. (27875063)
2016
48
Pyoderma gangrenosum associated with alitretinoin therapy. (27051854)
2016
49
Cutaneous malakoplakia masquerading as pyoderma gangrenosum. (27524799)
2016
50
Chronic recurrent multifocal osteomyelitis in association with pyoderma gangraenosum. (27585859)
2016

Variations for Pyoderma

About this section

Expression for genes affiliated with Pyoderma

About this section
Search GEO for disease gene expression data for Pyoderma.

Pathways for genes affiliated with Pyoderma

About this section

Pathways related to Pyoderma according to GeneCards Suite gene sharing:

(show all 34)
idSuper pathwaysScoreTop Affiliating Genes
19.9CXCL8, TNF
29.9CXCL8, TNF
39.9NOD2, TNF
4
Show member pathways
9.6MEFV, NOD2, PSTPIP1
59.6CXCL8, ITGB2, TNF
69.6CXCL8, ITGB2, TNF
79.6CXCL8, ITGB2, TNF
89.6CXCL8, ITGB2, TNF
99.5IL1R1, MMP9
10
Show member pathways
9.5CXCL8, IL1R1, TNF
119.5CXCL8, IL1R1, TNF
12
Show member pathways
9.5CXCL8, IL1R1, TNF
13
Show member pathways
9.4CXCL8, IFNA2, TNF
149.4CXCL8, IFNA2, TNF
159.4BTK, IL1R1, TNF
169.4ITGB2, MMP9, TNF
17
Show member pathways
9.4CXCL8, MMP9, TNF
189.4CXCL8, MMP9, TNF
199.3MMP9, NOD2, TNF
209.3IL1R1, MMP9, TNF
219.2CXCL8, IL1R1, ITGB2, TNF
229.1IFNA2, ITGB2, NOD2, TNF
239.1BTK, CXCL8, IL1R1, TNF
249.1CXCL8, F3, TNF
25
Show member pathways
9.1MMP10, MMP9, TNF
269.1CXCL8, ITGB2, MMP9, TNF
279.0CXCL8, MMP10, MMP9
289.0CXCL8, IL1R1, MMP9, TNF
29
Show member pathways
8.8C7, F3, ITGB2
308.8F3, ITGB2, MMP9
31
Show member pathways
8.5BTK, CXCL8, IFNA2, MMP9, TNF
32
Show member pathways
7.9CXCL8, IFNA2, IL1R1, ITGB2, MMP9, NOD2
33
Show member pathways
6.9BTK, CXCL8, F3, IFNA2, IL1R1, MEFV
34
Show member pathways
6.4BTK, C7, CXCL8, IFNA2, IL1R1, ITGB2

GO Terms for genes affiliated with Pyoderma

About this section

Cellular components related to Pyoderma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:00099869.1F3, IL1R1, ITGB2, NOD2, TNF
2extracellular spaceGO:00056157.5CXCL8, F3, IFNA2, MMP10, MMP9, TNF
3extracellular regionGO:00055767.3C7, CXCL8, F3, IFNA2, IL1R1, MMP10

Biological processes related to Pyoderma according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1cellular extravasationGO:004512310.6ITGB2, TNF
2embryonic digestive tract developmentGO:004856610.6CXCL8, TNF
3positive regulation of interleukin-8 productionGO:003275710.4NOD2, TNF
4positive regulation of NIK/NF-kappaB signalingGO:190122410.2NOD2, TNF
5immune system processGO:00023769.9BTK, MEFV, NOD2, PSTPIP1
6defense responseGO:00069529.8CXCL8, IFNA2, NOD2, TNF
7positive regulation of vascular smooth muscle cell proliferationGO:19047079.7MMP9, TNF
8positive regulation of angiogenesisGO:00457669.6CXCL8, F3, ITGB2
9positive regulation of NF-kappaB transcription factor activityGO:00510929.6BTK, ITGB2, NOD2, TNF
10cytokine-mediated signaling pathwayGO:00192219.5F3, IFNA2, IL1R1
11inflammatory responseGO:00069549.3CXCL8, IFNA2, ITGB2, MEFV, PSTPIP1, TNF
12innate immune responseGO:00450878.9BTK, C7, IFNA2, MEFV, NOD2, PSTPIP1

Molecular functions related to Pyoderma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protease bindingGO:00020209.0F3, IL1R1, TNF

Sources for Pyoderma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet